Novartis AG (NVS) Stock Price & Analysis

NVS$159.33-0.87 -0.54%
Drug Manufacturers - GeneralMega CapHigh Quality
Compare
Market cap$300.91BEnterprise value$350.16BRevenue (TTM)$56.31BMarket positionTop 5%

Score

39
Bearish
Value
36
Quality
65
Growth
17

AI Analysis

Snapshot

Novartis AG doesn’t screen as a clean setup today — Stocklytics 39/100 leaves more to prove. Under the hood: P/E 31.6, rich vs its own history, plus revenue compounding ~8% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

36
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

17
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

65
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Novartis AG (NVS) last printed $159.33. Equity value is $300.91B. Trailing earnings multiple 30.44. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$49.44B$43.4B$46.1B$48.68B$49.9B$43.97B$43.46B$46.66B$51.72B$54.81B

About

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis AG (NVS) Stock Price & Analysis

NVS price $159.33 -0.87 -0.54%

Ticker
NVS
Price
$159.33
Change
-0.87 -0.54%
Market cap
$300.91B
P/E
30.44
Forward P/E
16.36
Dividend yield
2.76%
Beta
0.41
Sector
Healthcare
Industry
Drug Manufacturers - General
Stocklytics score
39
Value
36
Quality
65
Growth
17

Stocklytics score rationale: value 36, quality 65, growth 17.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener